Literature DB >> 19857619

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Anthony Feher1, Andrew Koivunemi, Mark Koivunemi, Robyn K Fuchs, David B Burr, Roger J Phipps, Susan Reinwald, Matthew R Allen.   

Abstract

The suppressive effects of bisphosphonates (BPs) on bone remodeling are clear yet there is conflicting data concerning the effects of BPs on modeling (specifically formation modeling on the periosteal surface). The normal periosteal expansion that occurs during aging has significant benefits to maintaining/improving the bones' mechanical properties and thus it is important to understand whether BPs affect this bone surface. Therefore, the purpose of this study was to determine the effects of BPs on periosteal bone formation modeling induced by ovariectomy (OVX) and mechanical loading. Six-month-old Sprague-Dawley OVX rats (n=60; 12/group) were administered vehicle, risedronate, alendronate, or zoledronate at doses used clinically for treatment of post-menopausal osteoporosis. Three weeks after initiating BP treatment, all animals underwent in vivo ulnar loading of the right limb every other day for 1 week (3 total sessions). Periosteal surface mineral apposition rate, mineralizing surface, and bone formation rate were determined at the mid-diaphysis of both loaded (right) and non-loaded (left) ulnae. There was no significant effect of any of the BPs on periosteal bone formation parameters compared to VEH-treated animals in the non-loaded limb, suggesting that BP treatment does not compromise the normal periosteal expansion associated with estrogen loss. Mechanical loading significantly increased BFR in the loaded limb compared to the non-loaded limb in all BP-treated groups, with no difference in the magnitude of this effect among the various BPs. Collectively, these data show that BP treatment, at doses comparable to those used for treatment of post-menopausal osteoporosis, (1) does not alter the periosteal formation activity that occurs in the absence of estrogen and (2) allows normal stimulation of periosteal bone formation in response to the anabolic stimulation of mechanical loading. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857619     DOI: 10.1016/j.bone.2009.10.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  25 in total

Review 1.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

2.  C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.

Authors:  Tomas E Meijome; Jenna T B Ekwealor; R Adam Hooker; Ying-Hua Cheng; Wendy A Ciovacco; Sanjeev M Balamohan; Trishya L Srinivasan; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2015-10-06       Impact factor: 4.429

3.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

4.  Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.

Authors:  C Jerome; M Missbach; R Gamse
Journal:  Osteoporos Int       Date:  2011-02-10       Impact factor: 4.507

5.  Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.

Authors:  C Jerome; M Missbach; R Gamse
Journal:  Osteoporos Int       Date:  2011-03-05       Impact factor: 4.507

Review 6.  Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing.

Authors:  Cheng Cheng; Dolores Shoback
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

7.  Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.

Authors:  David J Olivos; Marta Alvarez; Ying-Hua Cheng; Richard Adam Hooker; Wendy A Ciovacco; Monique Bethel; Haley McGough; Christopher Yim; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

Review 8.  The effect of antiresorptives on bone quality.

Authors:  Robert R Recker; Laura Armas
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

9.  Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependent.

Authors:  Eric R Smith; Matthew R Allen
Journal:  J Orthop Res       Date:  2013-03-13       Impact factor: 3.494

10.  Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.

Authors:  Nicolau Conte Neto; Luis C Spolidorio; Cleverton R Andrade; Alliny S Bastos; Morgana Guimarães; Elcio Marcantonio
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.